FDA moves to ease path for biosimilars as Trump seeks to cut drug costs – statnews.com
FDA moves to ease path for biosimilars as Trump seeks to cut drug costs statnews.com US FDA proposes moves…
FDA Approves First Treatment for MAS in Still Disease
The FDA has approved the interferon gamma-blocking antibody emapalumab-lzsg (Gamifant) for the treatment of macrophage activation syndrome (MAS)…